Oxytocin Panpharma

Medicinal product

(Invented) name

Oxytocin Panpharma

Active substance (s)

Oksitocinas

Strength

5 TV/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H01BB02, Oxytocin

Marketing authorisation holder

PANPHARMA, Prancūzija

Date of authorisation

2017-11-13

Date of renewal

2023-12-18

Documents

4163_Oxytocin Panpharma_perr2023-12-18.docx

4163_pakuotes lapelis_2023-12-18.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

HU/H/0657/001

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Ampulėje (1 ml) yra:	1 ml
Oksitocinas	5 TV/ml

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60520	74799	1074799	ampulė	1 ml N3		Receptinis	LT/1/17/4163/001	Netiekiama	-	-	No	-	-
98320	84420	1084420	ampulė	1 ml N5		Receptinis	LT/1/17/4163/002	Netiekiama	-	-	No	-	-
98321	84423	1084423	ampulė	1 ml N10		Receptinis	LT/1/17/4163/003	Netiekiama	-	-	No	-	-
98322	84424	1084424	ampulė	1 ml N50		Receptinis	LT/1/17/4163/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-03-28	Išregistruotas
2023-12-18	Perregistruotas
2017-11-13	Registruotas